GT Biopharma holds annual shareholder meeting

GT Biopharma held its annual stockholder meeting on Aug. 14, 2026.

• Stockholders selected four directors to serve on the board.
• The appointment of Weinberg & Company as independent accountant for the year ending Dec. 31, 2026 was ratified.
• A charter amendment authorizing a 1-for-10 to 1-for-30 reverse split, if implemented, was adopted; the board will set the ratio and timing.
• Two amendments to the 2022 Omnibus Incentive Plan were adopted, adding 3.5 million shares and an automatic annual increase feature.